Comments
Dr Reddy’s Laboratories today launched Sirolimus Tablets 1 mg and 2 mg, a therapeutic equivalent generic version of RAPAMUNE (Sirolimus) tablets in the US market on Monday , following the approval by the United States Food & Drug Administration (USFDA).
The Rapamune tablets brand had U.S. sales of approximately $206 million for the most recent twelve months ending in August 2014 according to IMS Health.
Dr Reddy’s Sirolimus tablets in 1 mg and 2 mg are available in bottle counts of 100.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.